Smoking Cessation at Lung Examination (Part 1): Findings and Lessons Learned from the NCI SCALE Collaboration Webinar-Smoking Cessation at Lung Examination (Part 1)

Video Transcription

Video Summary

The webinar hosted by the International Association for the Study of Lung Cancer (IASLC) focused on smoking cessation in the context of lung cancer screening. Dr. Benjamin Toll, along with a panel of experts including Dr. Park, Dr. Minix, Dr. Foley, and others, discussed key studies and findings from the Scale Collaboration. The discussions aimed to enhance understanding of tobacco treatment implementation, its effectiveness, and best practices in clinical contexts for lung cancer screening.<br /><br />Dr. Park presented the SCREEN-ASSIST trial, highlighting a model that integrated tobacco treatment into healthcare systems, aiming for sustainable smoking cessation practices. The trial involved hybrid clinical setups, integrating decision support tools and community service referrals, ultimately striving to improve patient health outcomes.<br /><br />Dr. Minix's presentation focused on treatment modalities in a study conducted at MD Anderson, assessing the impact of various tobacco treatment integration levels within lung cancer screenings. The study explored the efficacy of integrated care models, finding that integrated approaches offered superior outcomes in promoting abstinence among smokers.<br /><br />Additionally, Dr. Foley discussed a type two hybrid effectiveness-implementation trial across various community sites, emphasizing the integration of cessation support within imaging facilities. Despite a lack of significant differences in quit rates between intervention and control groups, site-specific factors like internal champions and existing healthcare resources impacted implementation success.<br /><br />The panel also highlighted Dr. Ben-Yo's presentation on the PLUTO trial, which utilized an adaptive design to tailor smoking cessation treatments based on early treatment responses, achieving notable long-term abstinence rates.<br /><br />Overall, while each study presented distinct approaches and findings, they collectively underscored the importance of integrating tailored and intensive smoking cessation interventions within lung cancer screening programs to enhance patient outcomes and adherence to screening protocols.

Keywords

IASLC

smoking cessation

lung cancer screening

tobacco treatment

SCREEN-ASSIST trial

integrated care models

MD Anderson

community service referrals

effectiveness-implementation trial

PLUTO trial

adaptive design

patient health outcomes